Pharmacogenomics and Pharmacogenetics Section

Introduction

Sections: Pharmacogenomics and Pharmacogenetics: Introduction

Last Updated 10 September 2010

Introduction

Aims

•  Promotion of exchange of pharmacogenetic knowledge by organisation of symposia and workshops in the field of pharmacogenetics and -genomics

•  Evaluation of the clinical impact of pharmacogenetics

•  Development of ethical standards of pharmacogenetics

Section on Pharmacogenetics and Pharmacogenetics

The Section was established during the IUPHAR General Assembly held in San Francisco in 2002. It was subsequently re-established in the summer of 2006 after the World Congress of Pharmacology in Beijing, China. It consists of an increasing number of distinguished scientists from different continents, covering expertise from molecular biology to ethical aspect of pharmacogenetics. The Section cooperates with the IUPHAR member societies of the Pacific Rim Association for Clinical Pharmacogenetics (PRACP) and the European Association for Clinical Pharmacology and Therapeutic (EACPT).

Background

Pharmacotherapy optimization through individual drug therapy is one of the major goals of clinical medicine. Over the last decades it has been clearly shown that genetics play a significant role in the pharmacokinetics of drugs and there is an increasing understanding of the genetic background among individuals and ethnic groups with regard to drug efficacy and response. Pharmacogenetics has developed into one of the most important subfields of clinical pharmacology and plays a significant role in the drug development process.

Aims and scopes

The Section will

• Promote exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and –genomics.
• Evaluate the clinical impact of pharmacogenetics
• Cooperate with drug-related pharmacogenetic database
• Create a population based “biobank” to conduct translational research in clinical pharmacogenomics
• Establish international collaborative clinical studies to investigate the benefits of pharmacogenetics.

Past activites

Courses and symposia with the support of IUPHAR:

DIRAC PhD course on Pharmacogenetics / -genomics, Helsingør, Denmark 26.-29.08.2008 [DIRAC program.pdf]

Symposium “Pharmacogenomics in Clinical Practice” at XI Saõ Paulo Research Conference on Molecular Medicine and Pharmacogenetics. 18. - 20.09.2008, Saõ Paulo, Brazil [Sao Paulo Congress Report.pdf]

Workshop “Implementation and Obstacles of Pharmacogenetics in Clinical Practice”. WorldPharma 2010, 20.07.2010, Copenhagen, Denmark [WorldPharma2010 SW12.pdf]

Workshops will be preferably organised in cooperation with academic learned societies or regulatory bodies.